![H. Moses Murdock on Twitter: "4/ 🎯 What about target doses? CHAMP-HF showed we collectively do a poor job of optimizing GDMT. 👇🏾 https://t.co/cVqWpwXroP In their supplement, we find "Target Doses of H. Moses Murdock on Twitter: "4/ 🎯 What about target doses? CHAMP-HF showed we collectively do a poor job of optimizing GDMT. 👇🏾 https://t.co/cVqWpwXroP In their supplement, we find "Target Doses of](https://pbs.twimg.com/media/E392auOWQAQopjs.jpg)
H. Moses Murdock on Twitter: "4/ 🎯 What about target doses? CHAMP-HF showed we collectively do a poor job of optimizing GDMT. 👇🏾 https://t.co/cVqWpwXroP In their supplement, we find "Target Doses of
![A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension | Hypertension A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/541fb68f-c651-49d7-9c87-685305ce4820/hy0650737002.jpg)
A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension | Hypertension
![Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a0dfa3b2d2a31d4619fe218bac0474437a41e38/8-TableIII-1.png)
Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar
![Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a0dfa3b2d2a31d4619fe218bac0474437a41e38/8-TableII-1.png)
Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers. | Semantic Scholar
![Pharmacokinetic Parameters of Losartan and EXP3174 after In- travenous... | Download Scientific Diagram Pharmacokinetic Parameters of Losartan and EXP3174 after In- travenous... | Download Scientific Diagram](https://www.researchgate.net/publication/11201959/figure/tbl1/AS:601658975342596@1520458086157/Pharmacokinetic-Parameters-of-Losartan-and-EXP3174-after-In-travenous-Administration-of.png)
Pharmacokinetic Parameters of Losartan and EXP3174 after In- travenous... | Download Scientific Diagram
![Table 1 from Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis. | Semantic Scholar Table 1 from Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dbaef777f37e2bea5e12e5f5e8ebbb59dac06d93/2-Table1-1.png)
Table 1 from Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis. | Semantic Scholar
![Table 1 from Comparisons of the pharmacokinetics and tolerability of fixed- dose combinations of amlodipine besylate/losartan and amlodipine camsylate/ losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence ... Table 1 from Comparisons of the pharmacokinetics and tolerability of fixed- dose combinations of amlodipine besylate/losartan and amlodipine camsylate/ losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence ...](https://d3i71xaburhd42.cloudfront.net/cff9498af31927e2b67f0f3378cecb1966fdd148/5-Table1-1.png)
Table 1 from Comparisons of the pharmacokinetics and tolerability of fixed- dose combinations of amlodipine besylate/losartan and amlodipine camsylate/ losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence ...
![These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS.LOSARTAN POTASSIUM tablets, for oral useInitial U.S. Approval: These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS.LOSARTAN POTASSIUM tablets, for oral useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Losartan-Table3.jpg&id=511464)
These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS.LOSARTAN POTASSIUM tablets, for oral useInitial U.S. Approval:
![Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits](https://ijp-online.com/articles/2021/53/6/images/Indian%20J%20Pharmacol_2021_53_6_465_334359_t6.jpg)